Literature DB >> 21859735

The proportion of activated B-cell like subtype among de novo diffuse large B-cell lymphoma increases with age.

Sylvain Mareschal, Hélène Lanic, Philippe Ruminy, Christian Bastard, Hervé Tilly, Fabrice Jardin.   

Abstract

Mesh:

Year:  2011        PMID: 21859735      PMCID: PMC3232277          DOI: 10.3324/haematol.2011.050617

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  12 in total

1.  Novel Ig V gene features of t(14;18) and t(3;14) de novo diffuse large B-cell lymphoma displaying germinal center-B cell like and non-germinal center-B cell like markers.

Authors:  F Jardin; S S Sahota; P Ruminy; F Parmentier; J M Picquenot; V Rainville; G Buchonnet; S Leprêtre; H Tilly; C Bastard
Journal:  Leukemia       Date:  2006-09-14       Impact factor: 11.528

2.  Interim positron emission tomography scan associated with international prognostic index and germinal center B cell-like signature as prognostic index in diffuse large B-cell lymphoma.

Authors:  Hélène Lanic; Sylvain Mareschal; Férial Mechken; Jean-Michel Picquenot; Marie Cornic; Catherine Maingonnat; Philippe Bertrand; Florian Clatot; Elodie Bohers; Aspasia Stamatoullas; Stéphane Leprêtre; Vinciane Rainville; Philippe Ruminy; Christian Bastard; Hervé Tilly; Stéphanie Becker; Pierre Vera; Fabrice Jardin
Journal:  Leuk Lymphoma       Date:  2011-08-01

3.  Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial.

Authors:  Frédéric Peyrade; Fabrice Jardin; Catherine Thieblemont; Antoine Thyss; Jean-François Emile; Sylvie Castaigne; Bertrand Coiffier; Corinne Haioun; Serge Bologna; Olivier Fitoussi; Gérard Lepeu; Christophe Fruchart; Dominique Bordessoule; Michel Blanc; Richard Delarue; Maud Janvier; Bruno Salles; Marc André; Marion Fournier; Philippe Gaulard; Hervé Tilly
Journal:  Lancet Oncol       Date:  2011-04-07       Impact factor: 41.316

4.  The isotype of the BCR as a surrogate for the GCB and ABC molecular subtypes in diffuse large B-cell lymphoma.

Authors:  P Ruminy; P Etancelin; L Couronné; F Parmentier; V Rainville; S Mareschal; E Bohers; C Burgot; M Cornic; P Bertrand; B Lenormand; J-M Picquenot; F Jardin; H Tilly; C Bastard
Journal:  Leukemia       Date:  2011-01-14       Impact factor: 11.528

5.  Diffuse large B-cell lymphoma in pediatric patients belongs predominantly to the germinal-center type B-cell lymphomas: a clinicopathologic analysis of cases included in the German BFM (Berlin-Frankfurt-Munster) Multicenter Trial.

Authors:  Ilske Oschlies; Wolfram Klapper; Martin Zimmermann; Matthias Krams; Hans-Heinrich Wacker; Birgit Burkhardt; Lana Harder; Reiner Siebert; Alfred Reiter; Reza Parwaresch
Journal:  Blood       Date:  2006-01-19       Impact factor: 22.113

6.  Immunoglobulin VH gene expression in human aging.

Authors:  X Wang; B D Stollar
Journal:  Clin Immunol       Date:  1999-11       Impact factor: 3.969

7.  Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways.

Authors:  Georg Lenz; George W Wright; N C Tolga Emre; Holger Kohlhammer; Sandeep S Dave; R Eric Davis; Shannon Carty; Lloyd T Lam; A L Shaffer; Wenming Xiao; John Powell; Andreas Rosenwald; German Ott; Hans Konrad Muller-Hermelink; Randy D Gascoyne; Joseph M Connors; Elias Campo; Elaine S Jaffe; Jan Delabie; Erlend B Smeland; Lisa M Rimsza; Richard I Fisher; Dennis D Weisenburger; Wing C Chan; Louis M Staudt
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-02       Impact factor: 11.205

8.  The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.

Authors:  Andreas Rosenwald; George Wright; Wing C Chan; Joseph M Connors; Elias Campo; Richard I Fisher; Randy D Gascoyne; H Konrad Muller-Hermelink; Erlend B Smeland; Jena M Giltnane; Elaine M Hurt; Hong Zhao; Lauren Averett; Liming Yang; Wyndham H Wilson; Elaine S Jaffe; Richard Simon; Richard D Klausner; John Powell; Patricia L Duffey; Dan L Longo; Timothy C Greiner; Dennis D Weisenburger; Warren G Sanger; Bhavana J Dave; James C Lynch; Julie Vose; James O Armitage; Emilio Montserrat; Armando López-Guillermo; Thomas M Grogan; Thomas P Miller; Michel LeBlanc; German Ott; Stein Kvaloy; Jan Delabie; Harald Holte; Peter Krajci; Trond Stokke; Louis M Staudt
Journal:  N Engl J Med       Date:  2002-06-20       Impact factor: 91.245

9.  Stromal gene signatures in large-B-cell lymphomas.

Authors:  G Lenz; G Wright; S S Dave; W Xiao; J Powell; H Zhao; W Xu; B Tan; N Goldschmidt; J Iqbal; J Vose; M Bast; K Fu; D D Weisenburger; T C Greiner; J O Armitage; A Kyle; L May; R D Gascoyne; J M Connors; G Troen; H Holte; S Kvaloy; D Dierickx; G Verhoef; J Delabie; E B Smeland; P Jares; A Martinez; A Lopez-Guillermo; E Montserrat; E Campo; R M Braziel; T P Miller; L M Rimsza; J R Cook; B Pohlman; J Sweetenham; R R Tubbs; R I Fisher; E Hartmann; A Rosenwald; G Ott; H-K Muller-Hermelink; D Wrench; T A Lister; E S Jaffe; W H Wilson; W C Chan; L M Staudt
Journal:  N Engl J Med       Date:  2008-11-27       Impact factor: 91.245

10.  B-cell diversity decreases in old age and is correlated with poor health status.

Authors:  Kate L Gibson; Yu-Chang Wu; Yvonne Barnett; Orla Duggan; Robert Vaughan; Elli Kondeatis; Bengt-Olof Nilsson; Anders Wikby; David Kipling; Deborah K Dunn-Walters
Journal:  Aging Cell       Date:  2008-11-05       Impact factor: 9.304

View more
  28 in total

1.  Classification of diffuse large B-cell lymphoma by immunohistochemistry demonstrates that elderly patients are more common in the non-GC subgroup and younger patients in the GC subgroup.

Authors:  Ulf Thunberg; Gunilla Enblad; Mattias Berglund
Journal:  Haematologica       Date:  2012-02       Impact factor: 9.941

2.  Management Strategies for Elderly Patients with Diffuse Large B-Cell Lymphoma.

Authors:  Loretta J Nastoupil; Rajni Sinha; Christopher R Flowers
Journal:  Eur Oncol Haematol       Date:  2012-05

3.  ATM deficiency promotes development of murine B-cell lymphomas that resemble diffuse large B-cell lymphoma in humans.

Authors:  Karen S Hathcock; Hesed M Padilla-Nash; Jordi Camps; Dong-Mi Shin; Daniel Triner; Arthur L Shaffer; Robert W Maul; Seth M Steinberg; Patricia J Gearhart; Louis M Staudt; Herbert C Morse; Thomas Ried; Richard J Hodes
Journal:  Blood       Date:  2015-09-23       Impact factor: 22.113

Review 4.  The biology of aging and lymphoma: a complex interplay.

Authors:  Clémentine Sarkozy; Gilles Salles; Claire Falandry
Journal:  Curr Oncol Rep       Date:  2015-07       Impact factor: 5.075

5.  Outcomes of very elderly patients with aggressive B-cell non-Hodgkin lymphoma treated with reduced-dose chemotherapy.

Authors:  Futoshi Iioka; Kiyotaka Izumi; Yoshimasa Kamoda; Takashi Akasaka; Hitoshi Ohno
Journal:  Int J Clin Oncol       Date:  2015-10-13       Impact factor: 3.402

Review 6.  Role of anthracycline and comprehensive geriatric assessment for elderly patients with diffuse large B-cell lymphoma.

Authors:  Richard J Lin; Madhusmita Behera; Catherine S Diefenbach; Christopher R Flowers
Journal:  Blood       Date:  2017-08-16       Impact factor: 22.113

Review 7.  Treating Diffuse Large B Cell Lymphoma in the Very Old or Frail Patients.

Authors:  Abhijeet Kumar; Muhammad Asad Fraz; Muhammad Usman; Saad Ullah Malik; Awais Ijaz; Ceren Durer; Seren Durer; Muhammad Junaid Tariq; Ali Younas Khan; Anum Qureshi; Warda Faridi; Aboo Nasar; Faiz Anwer
Journal:  Curr Treat Options Oncol       Date:  2018-09-01

Review 8.  Aggressive B-cell lymphomas: how many categories do we need?

Authors:  Jonathan W Said
Journal:  Mod Pathol       Date:  2012-11-16       Impact factor: 7.842

Review 9.  Management of aggressive B-cell NHLs in the AYA population: an adult vs pediatric perspective.

Authors:  Kieron Dunleavy; Thomas G Gross
Journal:  Blood       Date:  2018-06-12       Impact factor: 22.113

10.  Positron Emission Tomography-Directed Therapy for Patients With Limited-Stage Diffuse Large B-Cell Lymphoma: Results of Intergroup National Clinical Trials Network Study S1001.

Authors:  Daniel O Persky; Hongli Li; Deborah M Stephens; Steven I Park; Nancy L Bartlett; Lode J Swinnen; Paul M Barr; Jerome D Winegarden; Louis S Constine; Thomas J Fitzgerald; John P Leonard; Brad S Kahl; Michael L LeBlanc; Joo Y Song; Richard I Fisher; Lisa M Rimsza; Sonali M Smith; Thomas P Miller; Jonathan W Friedberg
Journal:  J Clin Oncol       Date:  2020-07-13       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.